While the Milan Criteria have been highly successful, they are not without limitations. One criticism is that they may exclude some patients who could benefit from a liver transplant. For example, patients with slightly larger tumors or more than three tumors may still have good outcomes but would be excluded under the Milan Criteria. Additionally, advances in imaging and tumor biomarkers may allow for better prediction of outcomes, potentially necessitating updates to the criteria in the future.
